Keyword leukemic myeloid blasts was used in the provided list of websites.
Patients and Caregivershttp://pageoverview.com/website-report/leukine.com
Leukine® (sargramostim) is contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (≥ 10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any components of Leukine, and for concomitant use with chemotherapy and radiotherapy. Please see Full Prescribing Information.
- Expected expiration: September 29th in 2018
- Creation date: September 30th in 1998
- Renew date: September 25th in 2016
- Google Analytics: 7433141-25